A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors

NCT05171790 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: QL1706 injection

Sponsor

Qilu Pharmaceutical Co., Ltd.